Graduate Institute of Clinical Medical Science, College of Medicine, China Medical University, Taichung, Taiwan, ROC.
Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, ROC.
Sci Rep. 2017 Jun 9;7(1):3199. doi: 10.1038/s41598-017-03523-0.
Asthma is an inflammatory disease and interleukin 12 (IL-12) may play a regulatory role in allergen-induced inflammation. The aim of this study was to investigate the association of polymorphisms in IL-12A/IL-12B with asthma. The asthma group included 198 adult patients and the control group included 453 individuals without asthma that were frequency-matched by gender and age. The distribution of genotypic and allelic frequencies of IL-12A rs568408 demonstrated significant differences between case and control groups. Specifically, the percentages of AA genotype of IL-12A rs568408 was significantly higher among asthmatic patients in Taiwan than healthy controls, compared to GG genotype. No significant difference was observed among the IL-12A rs2243115 and IL-12B rs3212227 genotypes between case and control groups. In addition, the A allele at IL-12A rs568408 was associated with more severe symptoms (P = 0.0085) among asthmatic patients. These results suggest that IL-12A rs568408 may contribute to the etiology and symptoms severity of asthma, indicating its usefulness as a predictive and diagnostic biomarker of asthma.
哮喘是一种炎症性疾病,白细胞介素 12(IL-12)可能在变应原诱导的炎症中发挥调节作用。本研究旨在探讨 IL-12A/IL-12B 基因多态性与哮喘的关系。哮喘组包括 198 例成年患者,对照组包括 453 例无哮喘的个体,按性别和年龄频率匹配。IL-12A rs568408 的基因型和等位基因频率分布在病例组和对照组之间存在显著差异。具体而言,与 GG 基因型相比,台湾哮喘患者 IL-12A rs568408 的 AA 基因型百分比明显更高。病例组和对照组之间 IL-12A rs2243115 和 IL-12B rs3212227 基因型无显著差异。此外,IL-12A rs568408 的 A 等位基因与哮喘患者更严重的症状相关(P=0.0085)。这些结果表明,IL-12A rs568408 可能有助于哮喘的病因和症状严重程度,表明其可用作哮喘的预测和诊断生物标志物。